Skip to main content
About the Industry Alliance
VIIA Advisory Board
Emerging Technology Companies
Latest News & Highlights
About Nuclear Medicine and Molecular Imaging
Value Initiative Newsletter
In the November 2021 issue, read interviews with Value Initiative Industry Alliance leaders Terri Wilson and Michael Pintek; explore Practical Dosimetry and the Future of Molecular Radiotherapies; Transforming Cardiac PET Myocardial Perfusion Imaging with N-13 Ammonia; and examine PET Scan Imaging's crucial role in diagnosing Alzheimer’s Disease. Plus, learn about
prostate cancer patient Paul Gruenberg's personal journey...and more!
the November 2021 Value Initiative Newsletter.
In the summer 2021 issue of the Value Initiative Newsletter, explore how SNMMI’s Value Initiative is charting the field’s path from molecules to the universe; take a deeper dive into therapies via a Siemens constructed Value Stream Map (VSM)—generated from interviews SNMMI and Siemens conducted with patients, practicing clinicians, and companies; and hear directly from pancreatic neuroendocrine tumor patient Cindy Lovelace.
the Summer 2021 Value Initiative Newsletter.
In the latest issue of the Value Initiative Newsletter, you'll learn more about how SNMMI is harnessing the power of collaboration to advance the field. Plus, read great articles from Value Initiative Industry Alliance Partners on
F-DCFPyL: From Innovation to Regulatory Submission,
Advancing Nuclear Medicine Through Reliability and Innovatio
n, as well as articles and interviews from new Transformative Leadership Circle members.
the Winter 2021 Value Initiative Newsletter.
In the the latest issue of the Value Initiative Newsletter, you'll learn more about "The Value of Nuclear Medicine and Molecular Imaging in the Time of COVID," get details on the new "AI" Taskforce, and read about early results from a recent PET Imaging survey. Plus, read articles from Value Initiative Industry Alliance Partners on PET Imaging Use During COVID-19; The Future of Dosimetry; and Growing a Research-Oriented Radiopharmaceutical Business.
the Summer 2020 Value Initiative Newsletter.
The latest issue of the Value Initiative Newsletter highlights the vision for "Value Initiative 2.0," and SNMMI's efforts to spotlight the sector’s rapid growth in therapeutics and targeted radionuclide therapy. Plus, read insightful articles from Value Initiative Industry Alliance Partners on topics including: Improving lives through nuclear medicine, Results From a Preliminary Survey on Axumin® (Fluciclovine F 18) Usage, and "Domestic Radioisotope Supply – Driving Solutions for Patient Healthcare Through Innovation, Collaboration and Shared Commitment."
the February 2020 Value Initiative Newsletter.
The latest issue of the Value Initiative Newsletter highlights the recent briefing on Capitol Hill to discuss the importance of nuclear medicine, diagnostic radiopharmaceuticals, and H.R. 3772. Plus, read insightful articles from Value Initiative Industry Alliance Partners on topics including: Radioligand Therapy in the Treatment of Cancer; USP <825>; and Why Quality Matters to Quantification.
the September 2019 Value Initiative Newsletter.
The latest issue of the Value Initiative Newsletter recaps the significant progress made in 2018, and highlights upcoming initiatives for 2019. In addition, the issue features submissions from Value Initiative Industry Alliance Partners, providing a different and enlightening perspective on the future of the field.
the January 2019 Value Initiative Newsletter.
SNMMI created the Value Initiative, a roadmap for dealing with challenges and demonstrating the true value of the field to a broad set of stakeholders—medical students and professionals, industry partners, regulators, patients, and the public. In this first issue of the Value Initiative Newsletter, receive an update on the initiative’s goals and progress.
the June 2018 Value Initiative Newsletter.
Latest News & Highlights